- Home
- AXSM vs GFF Comparison
AXSM vs GFF Comparison
Compare AXSM & GFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- GFF
- Stock Information
- Founded
- AXSM 2012
- GFF 1959
- Country
- AXSM United States
- GFF United States
- Employees
- AXSM N/A
- GFF N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- GFF Building Products
- Sector
- AXSM Health Care
- GFF Industrials
- Exchange
- AXSM Nasdaq
- GFF Nasdaq
- Market Cap
- AXSM 4.7B
- GFF 3.8B
- IPO Year
- AXSM 2015
- GFF N/A
- Fundamental
- Price
- AXSM $90.73
- GFF $72.76
- Analyst Decision
- AXSM Strong Buy
- GFF Strong Buy
- Analyst Count
- AXSM 14
- GFF 4
- Target Price
- AXSM $125.93
- GFF $89.25
- AVG Volume (30 Days)
- AXSM 499.7K
- GFF 393.2K
- Earning Date
- AXSM 02-18-2025
- GFF 02-05-2025
- Dividend Yield
- AXSM N/A
- GFF 0.99%
- EPS Growth
- AXSM N/A
- GFF 197.89
- EPS
- AXSM N/A
- GFF 4.23
- Revenue
- AXSM $338,457,000.00
- GFF $2,623,520,000.00
- Revenue This Year
- AXSM $44.89
- GFF $0.93
- Revenue Next Year
- AXSM $68.41
- GFF $3.10
- P/E Ratio
- AXSM N/A
- GFF $17.22
- Revenue Growth
- AXSM 51.47
- GFF N/A
- 52 Week Low
- AXSM $64.11
- GFF $55.01
- 52 Week High
- AXSM $105.00
- GFF $86.73
- Technical
- Relative Strength Index (RSI)
- AXSM 42.16
- GFF 38.14
- Support Level
- AXSM $89.09
- GFF $71.01
- Resistance Level
- AXSM $94.64
- GFF $82.32
- Average True Range (ATR)
- AXSM 3.64
- GFF 2.21
- MACD
- AXSM -1.14
- GFF -1.56
- Stochastic Oscillator
- AXSM 20.64
- GFF 14.47
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About GFF Griffon Corporation
Griffon Corp manufactures and markets residential, commercial and industrial garage doors to professional installing dealers and home center retail chains. It also provides non-powered landscaping products for homeowners and professionals. Its operating segments include Consumer and Professional Products and Home and Building Products. The company generates a majority of its revenue from the Home and Building Products segment.